Phio Pharmaceuticals Corp (PHIO) Stock Price, Quote & News

Company Profile

Phio Pharmaceuticals Corp., a a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma a...

Industry: Biotechnology

Sector: Healthcare

Phone: 508 767 3861

Website: phiopharma.com

Address:

11 Apex Drive, Suite 300A PMB 2006, Marlborough, United States

SmurfVillage Jan. 9 at 4:01 PM

$PHIO Reminder that Phio has already released strong interim data, the full pathology results for the final, highest-dose cohort (Cohort 5) are expected in Q1 2026. We are looking for consistency in "complete responses" (100% tumor clearance). Previous interim data for this cohort showed one patient with 100% clearance and another with over 90%,

0 · Reply

SuperGreenToday Jan. 9 at 2:26 PM

$PHIO

0 · Reply

TBONEYO Jan. 9 at 2:02 PM

$PHIO

0 · Reply

Poorman96 Jan. 9 at 11:47 AM

$PHIO could today be the beginning?

0 · Reply

DosGatos Jan. 8 at 4:58 PM

$PHIO Is it a SCAM?

1 · Reply

Poorman96 Jan. 8 at 2:14 PM

$PHIO let's go. Someone poke it I'm broke 😂

0 · Reply

HaroldH Jan. 8 at 12:04 PM

@MS_Tammy in 6 Jan post you said that $PHIO insiders had bought 406,800 shares in past 6 months but I can only find insiders having bought 26,000 shares in past 6 months. What is true is that insiders on the board awarded themselves 386,500 shares to themselves at no cost to themselves. For me this puts a very different complexion on the situation. What do you think. I remain bearish until I see evidence to support a bullish position.

3 · Reply

HaroldH Jan. 8 at 7:41 AM

$PHIO Since Nov 2025 every high has been lower than the previous high and every low has been lower than the previous low. No reason to buy!

2 · Reply